Insiders at Covid-19 Vaccine Makers Sold Nearly $500 Million of Stock Last Year
(From The Wall Street Journal)
In dollar terms, much of the sales came at a single company, Moderna, maker of one of two Covid-19 vaccines authorized for use in the U.S. Executives and a director there sold more than $321 million of their stock in more than 700 transactions. Merck MRK -0.77%& Co. insiders sold $58 million of their shares. At Novavax Inc.,NVAX +7.28%executives sold more than $40 million of their shares after the company’s vaccine hit milestones in August and September.
This article was originally posted here: https://www.ac2news.com/2021/02/insiders-at-covid-19-vaccine-makers-sold-nearly-500-million-of-stock-last-year/.
